## Abstract Polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS) is a wellβknown disease entity. Of the patients with monoclonal gammopathy without neuropathy, 25% develop a hematological malignancy during longβterm followβup. Whether the frequency of hematologic
β¦ LIBER β¦
Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy
β Scribed by Yasunori Nakagawa; Kenshi Suzuki; Toru Masaoka
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 296 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1341-321X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Risk factors for hematological malignanc
β
Marijke Eurelings; Nicolette C. Notermans; Niels W.C.J. Van de Donk; Henk M. Lok
π
Article
π
2001
π
John Wiley and Sons
π
English
β 127 KB
Clinical impact of cycling the administr
β
S. Hashino; L. Morita; H. Kanamori; M. Takahata; M. Onozawa; M. Nakagawa; T. Kaw
π
Article
π
2011
π
Springer
π
English
β 109 KB
Erythropoietin for the treatment of anem
β
T. J. Littlewood
π
Article
π
2001
π
John Wiley and Sons
π
English
β 152 KB
## Abstract Anemia is common in patients with hematological malignancy. Most patients will have their anemia attributed to the anemia of chronic disease. The anemia of chronic disease is caused by cytokine mediated suppression of erythropoiesis and low serum erythropoietin levels are found in the m
Pulmonary MRIβa new approach for the eva
β
C. Rieger; P. Herzog; R. Eibel; M. Fiegl; H. Ostermann
π
Article
π
2007
π
Springer-Verlag
π
English
β 311 KB
Applying the Multinational Association f
β
Nirmala Devi Baskaran; Gin Gin Gan; Kamarulzaman Adeeba
π
Article
π
2008
π
Springer
π
English
β 122 KB
Risk factors for infection and treatment
β
Cheol-In Kang; Doo Ryeon Chung; Kwan Soo Ko; Kyong Ran Peck; Jae-Hoon Song; The
π
Article
π
2011
π
Springer
π
English
β 124 KB